A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.

Autor: Swanson, Chad J.¹ (AUTHOR), Zhang, Yong¹ (AUTHOR), Dhadda, Shobha¹ (AUTHOR), Wang, Jinping¹ (AUTHOR), Kaplow, June¹ (AUTHOR), Lai, Robert Y. K.² (AUTHOR), Lannfelt, Lars^3,4 (AUTHOR), Bradley, Heather¹ (AUTHOR), Rabe, Martin¹ (AUTHOR), Koyama, Akihiko¹ (AUTHOR), Reyderman, Larisa¹ (AUTHOR), Berry, Donald A.⁵ (AUTHOR), Berry, Scott⁵ (AUTHOR), Gordon, Robert² (AUTHOR), Kramer, Lynn D.¹ (AUTHOR), Cummings, Jeffrey L.⁶ (AUTHOR) jcummings@cnsinnovations.com

Publikováno v: Alzheimer's Research & Therapy. 4/17/2021, Vol. 13 Issue 1, p1-14. 14p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease.

Autor: Rafii, Michael S., Sperling, Reisa A., Donohue, Michael C., Zhou, Jin, Roberts, Claire, Irizarry, Michael C., Dhadda, Shobha, Sethuraman, Gopalan, Kramer, Lynn D, Swanson, Chad J, Li, David, Krause, Stephen, Rissman, Robert A., Walter, Sarah, Raman, Rema, Johnson, Keith A., Aisen, Paul S.

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Apr2023, Vol. 19 Issue 4, p1227-1233, 7p

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.

Autor: Honig, Lawrence S., Barakos, Jerome, Dhadda, Shobha, Kanekiyo, Michio, Reyderman, Larisa, Irizarry, Michael, Kramer, Lynn D., Swanson, Chad J., Sabbagh, Marwan

Publikováno v: Alzheimer's & Dementia: Translational Research & Clinical Interventions; Jan2023, Vol. 9 Issue 1, p1-12, 12p